ArticleNuclear medicine communications2014

Considerations on absence of 68Ga-DOTA-F(ab')2-trastuzumab tracer uptake in HER2-overexpressing tumor lesions.

Thijs H Oude Munnink et al.PubMed ↗Publisher ↗

No numbers read from the abstract.